Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.
      Google Scholar   
Citation:
J Clin Oncol JCO2401875
Year:
2025
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
Parents:
3737  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
Breast    
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171; UG1CA232760, UG1CA233180, UG1CA233290, UG1CA233331, UG1CA233339, UG1CA233373, Breast Cancer Research Foundation BCRF-158; Cancer Prevention and Research Institute of Texas CPRIT, RP180712  
Corr. Author:
 
Authors:
                                   
Networks:
LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-OH007, LAPS-TX035, NY175   
Study
CALGB-9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: